295 related articles for article (PubMed ID: 20427501)
1. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
Kallas M; Green F; Hewison M; White C; Kline G
J Clin Endocrinol Metab; 2010 Jul; 95(7):3111-7. PubMed ID: 20427501
[TBL] [Abstract][Full Text] [Related]
2. A case of severe 1,25-dihydroxyvitamin D-mediated hypercalcemia due to a granulomatous disorder.
Zhang JT; Chan C; Kwun SY; Benson KA
J Clin Endocrinol Metab; 2012 Aug; 97(8):2579-83. PubMed ID: 22639294
[TBL] [Abstract][Full Text] [Related]
3. From hypocalcemia to hypercalcemia-an unusual clinical presentation of a patient with permanent postsurgical hypoparathyroidism.
Sundaresh V; Levine SN
J Clin Endocrinol Metab; 2015 Jan; 100(1):21-4. PubMed ID: 25303492
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia due to giant cell myocarditis: a case report.
Patel AM; Jessup M; Tomaszewski J; Doyle A
Prog Transplant; 2013 Dec; 23(4):365-7. PubMed ID: 24311400
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature.
Hygum K; Wulff CN; Harsløf T; Boysen AK; Rossen PB; Langdahl BL; Safwat AA
BMC Cancer; 2015 Oct; 15():788. PubMed ID: 26499069
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
8. Malakoplakia as a cause of severe hypercalcemia through ectopic 25-hydroxyvitamin D3 1-alpha-hydroxylase expression: A case report.
Chemouny JM; Sannier A; Hanouna G; Champion L; Vrtovsnik F; Daugas E
Medicine (Baltimore); 2018 Oct; 97(40):e12090. PubMed ID: 30290590
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol-mediated hypercalcemia: causes and course in 101 patients.
Donovan PJ; Sundac L; Pretorius CJ; d'Emden MC; McLeod DS
J Clin Endocrinol Metab; 2013 Oct; 98(10):4023-9. PubMed ID: 23979953
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia and elevated serum calcitriol in a patient with seminoma.
Grote TH; Hainsworth JD
Arch Intern Med; 1987 Dec; 147(12):2212-3. PubMed ID: 3689074
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis presenting as granulomatous myositis in a 16-year-old adolescent.
Orandi AB; Eutsler E; Ferguson C; White AJ; Kitcharoensakkul M
Pediatr Rheumatol Online J; 2016 Nov; 14(1):59. PubMed ID: 27832822
[TBL] [Abstract][Full Text] [Related]
13. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
14. Case report: vitamin D-mediated hypercalcemia in fungal infections.
Spindel SJ; Hamill RJ; Georghiou PR; Lacke CE; Green LK; Mallette LE
Am J Med Sci; 1995 Aug; 310(2):71-6. PubMed ID: 7631647
[TBL] [Abstract][Full Text] [Related]
15. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels.
Kazama JJ; Yamamoto T; Oya H; Yamamoto S; Sato Y; Sakurada J; Honda T; Endoh H; Narita I
J Bone Miner Res; 2010 Jun; 25(6):1455-9. PubMed ID: 20200933
[TBL] [Abstract][Full Text] [Related]
16. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
[TBL] [Abstract][Full Text] [Related]
18. Acute renal failure and hypercalcemia as onset in splenic lymphoma.
Gasperini ML; Gigante A; Barbano B; Liberatori M; Cianci R; Amoroso A
Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):848-50. PubMed ID: 21780556
[TBL] [Abstract][Full Text] [Related]
19. An unexpected cause of severe and refractory PTH-independent hypercalcemia: case report and literature review.
Rados DV; Furlanetto TW
Arch Endocrinol Metab; 2015 Jun; 59(3):277-80. PubMed ID: 26154099
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in Lung Cancer due to Simultaneously Elevated PTHrP and Ectopic Calcitriol Production: First Case Report.
Nemr S; Alluri S; Sundaramurthy D; Landry D; Braden G
Case Rep Oncol Med; 2017; 2017():2583217. PubMed ID: 28751994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
